The Union government has launched a nationwide regulatory crackdown on GLP-1 drugs
10.1016/j.phymed.2023.155165 53 KaganV
Short-acting but not long-acting glucagon-like protein-1 receptor agonists are associated with increased development of GERD and Barretts esophagus: results from a global healthcare database
When doctors prescribe Tresiba instead of GLP-1 medications Understanding when each medication is appropriate helps clarify why they are not interchangeable
[11] [12] For weight management, NICE (TA875, TA664) recommends these medications for adults with a BMI of 35 kg/m or more (or 32.5 kg/m or more for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds) who have at least one weight-related comorbidity and are receiving care through specialist weight management services
Lancet 360 , 268269 (2002)